-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Inotiv, Inc. to Participate in Upcoming Investor Conferences
Inotiv, Inc. to Participate in Upcoming Investor Conferences
WEST LAFAYETTE, Ind., May 16, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the "Company", "We", "Our" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, are scheduled to participate in the following investor conferences:
UBS Global Healthcare Conference
New York City
May 23-25, 2022
Group presentation: Tuesday, May 24, 2022 at 7:45 a.m. ET
Craig-Hallum Institutional Investor Conference
Virtual
June 1, 2022
One-on-one and small group meetings only
Jefferies Healthcare Conference
New York City
June 8-10, 2022
Group presentation: Friday, June 10, 2022 at 12:15 p.m. ET
A webcast of the UBS and Jefferies group presentations will be accessible on the Company's website at:
Inotiv management will be participating in one-on-one meetings during all events.
About Inotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company's products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here:
This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, the impact of the COVID-19 pandemic on the economy, demand for our services and products and our operations, including the measures taken by governmental authorities to address the pandemic, which may precipitate or exacerbate other risks and/or uncertainties, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.
Company Contact | Investor Relations |
Inotiv, Inc. | The Equity Group Inc. |
Beth A. Taylor, Chief Financial Officer | Kalle Ahl, CFA |
(765) 497-8381 | (212) 836-9614 |
btaylor@inotivco.com | kahl@equityny.com |
Devin Sullivan | |
(212) 836-9608 | |
dsullivan@equityny.com |
WEST LAFAYETTE, Ind., May 16, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the "Company", "We", "Our" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, are scheduled to participate in the following investor conferences:
印第安纳州西拉斐特,2022年5月16日(环球通讯社)伊诺诺夫公司(纳斯达克:NOTIV)(“公司”、“我们”、“我们的”或“伊诺维奇”)专门从事非临床和分析性药物发现和开发服务以及研究模型和相关产品和服务的领先合同研究机构今天宣布,总裁兼首席执行官小罗伯特·利苏尔和首席财务官贝丝·泰勒计划参加以下投资者会议:
UBS Global Healthcare Conference
New York City
May 23-25, 2022
Group presentation: Tuesday, May 24, 2022 at 7:45 a.m. ET
瑞银全球医疗保健大会
纽约市
2022年5月23日至25日
小组报告时间:2022年5月24日,星期二,上午7:45外星人
Craig-Hallum Institutional Investor Conference
Virtual
June 1, 2022
One-on-one and small group meetings only
克雷格-哈勒姆机构投资者大会
虚拟
2022年6月1日
仅限一对一和小组会议
Jefferies Healthcare Conference
New York City
June 8-10, 2022
Group presentation: Friday, June 10, 2022 at 12:15 p.m. ET
杰富瑞医疗会议
纽约市
2022年6月8日至10日
小组报告:2022年6月10日,星期五,下午12:15外星人
A webcast of the UBS and Jefferies group presentations will be accessible on the Company's website at:
瑞银集团和杰富瑞集团演示文稿的网络直播将在公司网站上收看,网址为:
Inotiv management will be participating in one-on-one meetings during all events.
在所有活动期间,INotiv管理层将参加一对一的会议。
About Inotiv
关于INotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company's products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here:
伊诺诺夫公司是一家领先的合同研究机构,致力于提供非临床和分析性药物发现和开发服务以及研究模型和相关产品和服务。该公司的产品和服务侧重于通过发现和临床前开发阶段带来新药和医疗设备,同时提高效率、改善数据并降低将新药推向市场的成本。INotiv致力于支持发现和开发目标,并帮助研究人员实现其关键研发项目的全部潜力,同时共同努力建设一个更健康、更安全的世界。有关Inov的更多信息可在此处找到:
This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, the impact of the COVID-19 pandemic on the economy, demand for our services and products and our operations, including the measures taken by governmental authorities to address the pandemic, which may precipitate or exacerbate other risks and/or uncertainties, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.
本新闻稿可能包含前瞻性陈述,这些陈述会受到风险和不确定性的影响,这些风险和不确定性包括但不限于与以下因素有关的风险和不确定性:市场和对我们产品和服务的需求的变化;产品和服务的开发、营销和销售;技术、行业和监管标准的变化;收购的时机和成功完成收购的时间;整合及其对业务和财务的影响;新冠肺炎大流行对经济的影响;对我们的服务和产品以及我们的运营的需求;包括政府当局为应对可能导致或加剧其他风险和/或不确定性的大流行而采取的措施;扩张及相关努力;以及其他各种市场和经营风险,包括公司提交给美国证券交易委员会的文件中详细说明的风险。
Company Contact | Investor Relations |
Inotiv, Inc. | The Equity Group Inc. |
Beth A. Taylor, Chief Financial Officer | Kalle Ahl, CFA |
(765) 497-8381 | (212) 836-9614 |
btaylor@inotivco.com | kahl@equityny.com |
Devin Sullivan | |
(212) 836-9608 | |
dsullivan@equityny.com |
公司联系人 | 投资者关系 |
伊诺诺夫公司 | 股权集团公司。 |
首席财务官贝丝·A·泰勒 | Kalle Ahl,CFA |
(765) 497-8381 | (212) 836-9614 |
邮箱:btaylor@intivco.com | 邮箱:kahl@equityny.com |
德文·沙利文 | |
(212) 836-9608 | |
邮箱:dsullivan@equityny.com |
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧